Article Image

Firebrick Pharma (ASX:FRE) raises $1 million via a placement

Firebrick Pharma has raised $1 million via a new share placement of 6.67 million shares at $0.15 per share.

The funds will be used to complete a Phase 3 Nasodine clinical trial, fund costs related to ongoing appeal expenses and support projected working capital for the next year.

 

More stories from Grafa
Check out other news relating to this publisher